The early transcriptional and post-transcriptional responses to fluconazole in sensitive and resistant Candida albicans

Abstract Candida albicans is a leading cause of fungal infections in immunocompromised patients. Management of candidemia relies on a few antifungal agents, with fluconazole being first line therapy. The emergence of fluconazole-resistant strains highlights the pressing need to improve our molecular...

Full description

Saved in:
Bibliographic Details
Main Authors: Irene Stevens, Fitz Gerald Silao, Susanne Huch, Honglian Liu, Kicki Ryman, Adriana Carvajal-Jimenez, Per O. Ljungdahl, Vicent Pelechano
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-80435-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846158540954140672
author Irene Stevens
Fitz Gerald Silao
Susanne Huch
Honglian Liu
Kicki Ryman
Adriana Carvajal-Jimenez
Per O. Ljungdahl
Vicent Pelechano
author_facet Irene Stevens
Fitz Gerald Silao
Susanne Huch
Honglian Liu
Kicki Ryman
Adriana Carvajal-Jimenez
Per O. Ljungdahl
Vicent Pelechano
author_sort Irene Stevens
collection DOAJ
description Abstract Candida albicans is a leading cause of fungal infections in immunocompromised patients. Management of candidemia relies on a few antifungal agents, with fluconazole being first line therapy. The emergence of fluconazole-resistant strains highlights the pressing need to improve our molecular understanding of the drug response mechanisms. By sequencing the 5’P mRNA degradation intermediates, we establish that co-translational mRNA decay occurs in C. albicans and characterize how in vivo 5´-3´ exonuclease degradation trails the last translating ribosome. Thus, the study of the 5’ Phosphorylated mRNA degradome (5PSeq) offers a simple and affordable way to measure ribosome dynamics and identify codon specific ribosome stalls in response to drugs and amino acid deprivation. Building upon this, we combine RNA-Seq and 5PSeq to study the early response of sensitive and resistant C. albicans isolates to fluconazole. Our results highlight that transcriptional responses, rather than changes in ribosome dynamics, are the main driver of Candida resistance to fluconazole.
format Article
id doaj-art-a416378a8c954ddcb8bccd8e9940aa4b
institution Kabale University
issn 2045-2322
language English
publishDate 2024-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-a416378a8c954ddcb8bccd8e9940aa4b2024-11-24T12:27:03ZengNature PortfolioScientific Reports2045-23222024-11-0114111010.1038/s41598-024-80435-wThe early transcriptional and post-transcriptional responses to fluconazole in sensitive and resistant Candida albicansIrene Stevens0Fitz Gerald Silao1Susanne Huch2Honglian Liu3Kicki Ryman4Adriana Carvajal-Jimenez5Per O. Ljungdahl6Vicent Pelechano7Science for Life Laboratory (SciLifeLab), Department of Microbiology, Tumor and Cell Biology, Karolinska InstitutetSciLifeLab, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm UniversityScience for Life Laboratory (SciLifeLab), Department of Microbiology, Tumor and Cell Biology, Karolinska InstitutetScience for Life Laboratory (SciLifeLab), Department of Microbiology, Tumor and Cell Biology, Karolinska InstitutetSciLifeLab, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm UniversityScience for Life Laboratory (SciLifeLab), Department of Microbiology, Tumor and Cell Biology, Karolinska InstitutetSciLifeLab, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm UniversityScience for Life Laboratory (SciLifeLab), Department of Microbiology, Tumor and Cell Biology, Karolinska InstitutetAbstract Candida albicans is a leading cause of fungal infections in immunocompromised patients. Management of candidemia relies on a few antifungal agents, with fluconazole being first line therapy. The emergence of fluconazole-resistant strains highlights the pressing need to improve our molecular understanding of the drug response mechanisms. By sequencing the 5’P mRNA degradation intermediates, we establish that co-translational mRNA decay occurs in C. albicans and characterize how in vivo 5´-3´ exonuclease degradation trails the last translating ribosome. Thus, the study of the 5’ Phosphorylated mRNA degradome (5PSeq) offers a simple and affordable way to measure ribosome dynamics and identify codon specific ribosome stalls in response to drugs and amino acid deprivation. Building upon this, we combine RNA-Seq and 5PSeq to study the early response of sensitive and resistant C. albicans isolates to fluconazole. Our results highlight that transcriptional responses, rather than changes in ribosome dynamics, are the main driver of Candida resistance to fluconazole.https://doi.org/10.1038/s41598-024-80435-w
spellingShingle Irene Stevens
Fitz Gerald Silao
Susanne Huch
Honglian Liu
Kicki Ryman
Adriana Carvajal-Jimenez
Per O. Ljungdahl
Vicent Pelechano
The early transcriptional and post-transcriptional responses to fluconazole in sensitive and resistant Candida albicans
Scientific Reports
title The early transcriptional and post-transcriptional responses to fluconazole in sensitive and resistant Candida albicans
title_full The early transcriptional and post-transcriptional responses to fluconazole in sensitive and resistant Candida albicans
title_fullStr The early transcriptional and post-transcriptional responses to fluconazole in sensitive and resistant Candida albicans
title_full_unstemmed The early transcriptional and post-transcriptional responses to fluconazole in sensitive and resistant Candida albicans
title_short The early transcriptional and post-transcriptional responses to fluconazole in sensitive and resistant Candida albicans
title_sort early transcriptional and post transcriptional responses to fluconazole in sensitive and resistant candida albicans
url https://doi.org/10.1038/s41598-024-80435-w
work_keys_str_mv AT irenestevens theearlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT fitzgeraldsilao theearlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT susannehuch theearlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT honglianliu theearlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT kickiryman theearlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT adrianacarvajaljimenez theearlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT peroljungdahl theearlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT vicentpelechano theearlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT irenestevens earlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT fitzgeraldsilao earlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT susannehuch earlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT honglianliu earlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT kickiryman earlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT adrianacarvajaljimenez earlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT peroljungdahl earlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans
AT vicentpelechano earlytranscriptionalandposttranscriptionalresponsestofluconazoleinsensitiveandresistantcandidaalbicans